Earendil - About the company
Earendil is a series D company based in Middletown (United States), founded in 2021. It operates as a Provider of AI-driven technology platforms that enable the discovery and development of protein therapeutics. Earendil has raised $787M in funding. The company has 69 active competitors, including 37 funded and 5 that have exited. Its top competitors include companies like Nimbus Therapeutics, Generate Biomedicines and Profluent Bio.
Company Details
Provider of AI-driven technology platforms that enable the discovery and development of protein therapeutics. It transform the discovery of protein therapeutics using deep learning and high-throughput biology. The company aims to deliver transformative medicines to patients worldwide through its innovative approaches.
- Website
- earendil.bio
- Email ID
- *****@helixon.com
Key Metrics
Founded Year
2021
Location
Middletown, United States
Stage
Series D
Total Funding
$787M in 1 round
Latest Funding Round
Investors
Ranked
23rd among 69 active competitors
Similar Companies
Sign up to download Earendil's company profile
Earendil's funding and investors
Earendil has raised a total funding of $787M over 1 round. Its latest funding round was a Series D round on Mar 20, 2026 for $*****. 6 investors participated in its latest round. Earendil has 7 institutional investors.
Here is the list of recent funding rounds of Earendil:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 20, 2026 | 7924359 | Series D | 7979460 | 4908299 | 9850482 | 4176772 |
Access funding benchmarks and valuations. Sign up today!View details of Earendil's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Earendil's Competitors and alternates
Top competitors of Earendil include Nimbus Therapeutics, Generate Biomedicines and Profluent Bio. Here is the list of Top 10 competitors of Earendil, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Nimbus Therapeutics 2009, Cambridge (United States), Series F | Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases | $637M | 68/100 | |
2nd |  Generate Biomedicines 2018, Somerville (United States), Public | Developer of a platform for generating novel protein-based therapeutic modalities | $693M | 66/100 | |
3rd |  Profluent Bio 2022, Berkeley (United States), Series B | Provider of an artificial intelligence-based protein design platform | $150M | 64/100 | |
4th |  Cradle 2021, Delft (Netherlands), Series B | Provider of chemoproteomics solutions for protein design and development | $103M | 64/100 | |
5th |  Seismic 2019, Watertown (United States), Series B | AI-assisted platform for drug discovery and development | $247M | 63/100 | |
6th |  Eikon 2019, Millbrae (United States), Public | Protein tracking and measuring tool for drug discovery | $1.16B | 62/100 | |
7th |  Vividion Therapeutics 2016, Oceanside (United States), Acquired | Pioneering chemoproteomics and covalent chemistry for precision therapeutics targeting undruggable disease drivers | $271M | 61/100 | |
8th | AI Proteins 2021, Boston (United States), Series A | Developer of de novo designed miniproteins for therapeutic applications | $59.7M | 59/100 | |
9th | Provider of next-generation proteomics platform for drug discovery and protein analysis | $63M | 56/100 | ||
10th | Orbit Discovery 2015, Oxford (United Kingdom), Series A | Developer of a drug discovery platforms by peptide display engine | $15.7M | 54/100 | |
23rd |  Earendil 2021, Middletown (United States), Series D | Provider of AI-driven technology platforms that enable the discovery and development of protein therapeutics | $787M | 47/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Earendil's competitors? Click here to see the top ones
Earendil's Investments and acquisitions
Earendil has made no investments or acquisitions yet.
News related to Earendil
Media has covered Earendil for a total of 8 events in the last 1 year, 2 of them have been about company updates and 2 about partnerships.
•
Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual ReportBusiness Wire•Mar 18, 2026•Sensorion, Sanofi, Dimension Capital Management, Pfizer and 7 others
•
US AI drug startup Earendil said to consider Hong Kong IPOTech in Asia•Mar 13, 2026•Earendil Labs, Dimension, Luminous Ventures, DST Global
•
WuXi XDC & Earendil Labs Collaborate on Payload-Linker TechnologyBenzinga•Feb 27, 2026•WuXi XDC, Earendil Labs
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Earendil
Explore our recently published companies
- Dl-Dental-2000 - Germany based, Unfunded company
- Kardiokl - Germany based, Unfunded company
- Blk-Care - Unfunded company
- DRPU Software - Ghaziabad based, 2008 founded, Public company
- Independent School District 625 - United States based, Funding Raised company
- Scioto Valley Solar One - Columbus based, 2021 founded, Funding Raised company
